Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

7.200 +0.030 (+0.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
33 34 Next >
This LSD Phase 2 Clinical Trial Is Showing Positive Results For Treatment Of Generalized Anxiety
A new scientific publication recently came out in the Biological Psychiatry journal announcing that results of an ongoing 
Via Benzinga
Why Are Solar Stocks FSLR, SPWR, ENPH, MAXN Moving Today?
Some solar stocks are on the move Thursday thanks to a few different catalysts that investors will want to keep in mind. 
Via InvestorPlace
Why Is ShiftPixy (PIXY) Stock Up 96% Today?
ShiftPixy (PIXY) stock is rocketing higher on Thursday after the company announced plans to spin off ShiftPixy Labs a sa public company. 
Via InvestorPlace
MindMed (MNMD) Stock Is Up on Psychedelics News
MindMed (MNMD) stock is on the move Wednesday following positive data from a Phase II clinical trial of MM-120 for anxiety. 
Via InvestorPlace
Psychedelic Stock Gainers And Losers From September 7, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.66% at $1.12 
Via Benzinga
Dear MNMD Stock Fans, Watch This Key Catalyst
The DEA is abandoning its quest to impose further psychedelic bans. MNMD stock will benefit from this news. 
Via InvestorPlace
Psychedelics May Make People Less Afraid of Death
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change... 
Via FinancialNewsMedia
Topics Supply Chain
Psychedelic Stock Gainers And Losers From September 6, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.90% at $0.30 LOSERS: 
Via Benzinga
Largest Psychedelic Stocks Up In August; Up 42% Since End Of June
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index are on average UP 18.5% in August. 
Via Talk Markets
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.41% at $0.29 
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. 
Via Benzinga
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist... 
Via Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.57% at $0.27 LOSERS: 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 31, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 31.95% at $0.24 
Via Benzinga
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... 
Via Benzinga
Compass Pathways, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.83% at $1.09 LOSERS: 
Via Benzinga
7 Psychedelics Stocks to Buy for a Big Drug Boom
These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments 
Via InvestorPlace
New Meme MindMed Executes 1:15 Reverse Stock Split
As of today, psychedelics biotech Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) will trade its common shares based on a 1-for-15 reverse shar 
Via Benzinga
Why Is Humanigen (HGEN) Stock Down 16% Today?
Humanigen (HGEN) stock is heading lower on Monday as investors react to a minimum price delisting notice from the Nasdaq Exchange. 
Via InvestorPlace
Clarus Therapeutics (CRXT) Stock Plunges Ahead of Aug. 31 Delisting
Clarus Therapeutics (CRXT) stock is falling hard on Monday as investors prepare for the stock to be delisted later this week. 
Via InvestorPlace
FAZE, PETZ: The Top 5 Short Squeeze Stocks to Watch This Week
Short squeeze stocks continue to be of interest to traders and we've got a list of the latest they need to know about this week. 
Via InvestorPlace
MindMed (MNMD) Stock Falls After Reverse Stock Split
MindMed's price should be less volatile after its 1-for-15 reverse stock split, making it less interesting to speculators 
Via InvestorPlace
Dow, Nasdaq Futures Lower Following Friday's Sell-Off; US Dollar Surges To 20-Year High
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 1,000 points in the previous session following speech from Federal Reserve Chairman... 
Via Benzinga
Catalent, Pinduoduo And 3 Stocks To Watch Heading Into Monday
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
How The 5 Cannabis Categories Performed Last Week
The cannabis sector consists of 5 distinctly different categories and they have each performed quite differently this past week, since the end of June and YTD. Only one is breaking even. 
Via Talk Markets
Largest Psychedelic Compound-Based Drug Stocks On A Roll - Up 50% Since End Of June
The Psychedelic Compounds-Based Drug Stocks Index went up 9.8% this week and is now up 49.5% since the end of June albeit down 32.6% YTD. 
Via Talk Markets
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 3.61% at $1.00 LOSERS: 
Via Benzinga
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
The clinical-stage biopharma company Mind Medicine -also known as MindMed (NASDAQ: MNMD), which recently made headlines reg 
Via Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 17.87% at $1.22 
Via Benzinga
What Is Going on With MindMed (MNMD) Stock Today?
Today, investors in MindMed and MNMD stock are pricing in a number of catalysts, driving the value of this speculative stock higher. 
Via InvestorPlace
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.